• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类毒素的不可逆性。一种改进的检测方法。

Irreversibility of toxoids. An improved method of testing.

作者信息

Stainer D W, Cameron J

出版信息

Dev Biol Stand. 1977;34:149-53.

PMID:838138
Abstract

Reversion of toxoid to toxin has been described by several authors yet present day regulations of all National Control Authorities have no specific requirements to check for this possibility. Most producers however have included some form of test in their own protocols for release. We have developed a satisfactory test for both diphtheria and tetanus toxoids which involves storing diluted toxoid at 20 degrees C and 34 degrees C for 6 weeks and performing a full toxicity test on the samples. In the case of diphtheria toxoid we have evidence that it may be dangerous to rely on the simpler guinea-pig skin test, since we have shown that several lots, while giving a negative skin reaction, exhibit diphtheria toxicity when given systemically. It is felt that an in vivo conversion to toxin may occur in some lots which would not be detected by the skin test.

摘要

几位作者曾描述过类毒素向毒素的逆转情况,但目前所有国家监管当局的规定都没有针对检查这种可能性的具体要求。然而,大多数生产商在其自身的放行规程中都纳入了某种形式的检测。我们已经为白喉和破伤风类毒素开发出了一种令人满意的检测方法,该方法包括将稀释后的类毒素在20摄氏度和34摄氏度下储存6周,并对样品进行全面的毒性检测。就白喉类毒素而言,我们有证据表明依赖更简单的豚鼠皮肤试验可能存在危险,因为我们已经表明,有几个批次虽然皮肤试验呈阴性反应,但全身给药时却表现出白喉毒性。有人认为,在某些批次中可能会发生体内向毒素转化的情况,而皮肤试验无法检测到这种转化。

相似文献

1
Irreversibility of toxoids. An improved method of testing.类毒素的不可逆性。一种改进的检测方法。
Dev Biol Stand. 1977;34:149-53.
2
Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.体外Vero细胞测定法和酶联免疫吸附测定法在美国对白喉和破伤风类毒素吸附疫苗效价测试中的应用。
Dev Biol Stand. 1996;86:207-15.
3
[Study of diphtheria and tetanus anatoxins by electrofocusing on an agarose gel].琼脂糖凝胶电聚焦法对白喉和破伤风类毒素的研究
J Biol Stand. 1989 Oct;17(4):343-52.
4
Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.保加利亚生产的吸附破伤风和白喉类毒素的效价控制
Prog Immunobiol Stand. 1970;4:548-52.
5
Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.吸附白喉-破伤风(DT)和白喉-破伤风-百日咳(DTP)疫苗中白喉抗毒素效价体内和体外测定方法的比较。
Dev Biol Stand. 1996;86:245-60.
6
Quantitative estimation of diphtheria and tetanus toxoids. 5. Comparative assays in mice and in guinea-pigs of two diphtheria toxoid preparations.白喉和破伤风类毒素的定量测定。5. 两种白喉类毒素制剂在小鼠和豚鼠体内的比较测定。
Biologicals. 1991 Oct;19(4):327-34. doi: 10.1016/s1045-1056(05)80022-3.
7
Preparative procedure for the purification of toxoids by gel filtration.通过凝胶过滤纯化类毒素的制备程序。
Appl Microbiol. 1967 May;15(3):616-21. doi: 10.1128/am.15.3.616-621.1967.
8
Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production.破伤风毒素功能的体外检测 BINACLE 试验:在疫苗生产过程中作为破伤风类毒素安全性检测替代方法的适用性。
Vaccine. 2013 Dec 16;31(52):6247-53. doi: 10.1016/j.vaccine.2013.10.028. Epub 2013 Oct 21.
9
Quantitative estimation of diphtheria and tetanus toxoids. 6. Use of different antibody titration methods for evaluation of immunogenicity in animals during potency assay of diphtheria toxoid.白喉和破伤风类毒素的定量测定。6. 在白喉类毒素效价测定中使用不同抗体滴定方法评估动物的免疫原性。
Biologicals. 1992 Jun;20(2):101-8. doi: 10.1016/s1045-1056(05)80057-0.
10
Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.评估豚鼠模型以评估对白喉、破伤风和无细胞百日咳(DTaP)疫苗及b型流感嗜血杆菌结合疫苗组成的联合疫苗不同成分免疫原性的干扰。
Biologicals. 1999 Jun;27(2):167-76. doi: 10.1006/biol.1999.0204.